Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_assertion type Assertion NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_head.
- NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_assertion description "[Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in clinical phase II for the treatment of Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_provenance.
- NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_assertion evidence source_evidence_literature NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_provenance.
- NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_assertion SIO_000772 22694849 NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_provenance.
- NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_assertion wasDerivedFrom befree-2016 NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_provenance.
- NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_assertion wasGeneratedBy ECO_0000203 NP989750.RA-EKMRFcclFL0Tr4xjBAQPwcM-ahNPLcv3DoIdMdgXrw130_provenance.